The trade war is taking a lot of the headlines and I am running out of time to write as they are replacing my computer soon, which will likely take a lot more time that it reasonably should but I wanted to write a quick note. 1. SRPT hit a grand slam. Not only did […]
March 19 Biotech Update
The sector continues to struggle a little as we have a lack of leadership and the old leaders are faltering. This morning does not dissuade from this analysis but it is early and the broader market is weak as well. In any case, this week should provide enough data to know whether or not another […]
May 5 Biotech Update
So clearly the strength later in the day did not play out yesterday and it ended up being yet another day with a strong open and a move that was faded all day. This selling carried over into this morning but perhaps this move will be faded as well. The sector (and market) are stuck […]
February 18 Biotech Update
I am back after a small break and I hope that nobody missed me. The market certainly did not miss me as not much has really happened on the news front or from a trading perspective. So at least my general sector thoughts are similar. There are a couple of current trades I want to […]
January 23 Biotech Update
It has been sort of a mixed bag with the sector despite some decent macro tailwinds with the European QE program. I am not saying the sector has been bad but I would have expected it to take more of a leadership position in the move higher whereas it seemed more to have been dragged […]
January 15 Biotech Update
I am back from JPM and will be highlighting what I learned over the next couple of days. I do want to reinforce what I was noting before and that is this market action speaks of a black swan coming. The quick drop in oil put a lot of pressure on positions. The action with […]
November 6 Biotech Update- ASH Abstract Galore
So we have a massive dump of information today that I want to touch on but it is not possible to cover everything. I will do a series of quick hits to cover as much as I can and get it out as early as possible. I will then spend the next week or so […]
October 22 Biotech Update
After a couple days of ripping higher the markets seemed to have calmed a little, which is understandable as this rip higher needs to be digested. The small caps tended to underperform the past couple days but it still might be a little too early to call it a trend and it could just be […]
October 17 Biotech Update
Looks like we are clearly having the bounce that everyone has been expecting (expect during the height of the selling where everyone expected the market to go to zero). This should have fairly significant legs even if it is a dead cat bounce. At this point the conservative stance is to stay agnostic about the […]
August 13 Biotech Update
It is really more of the same with the market drifting and large cap biotechs not really leading and the small caps having some nice moves. I know I have been talking about a potential scenario where small cap biotechs take over as the best performers in the space but it still seems up in […]
August 1 Biotech Update
Market was quite week in the pre-market and has recovered from those lows but has seemed to turn lower. Over the near term I think the upside is slightly higher than the downside, although I would not be surprised to see another leg lower before we get the bounce. Over the medium term, I think […]
July 29 Biotech Update
I had a great email last night that asked me to compare FMI and ILMN and so today I will go a step further and have a day of rumbles with FMI vs ILMN, CNAT vs GALT, and MRK vs PFE. I would talk a little about the broader market and sector but at this […]
May 28 Biotech Update
Of course, there was a storm last night that knocked out the entire internet connection at LSU, so this is going to be later than usual and I have not been able to follow the market at all. I am getting this posted by hook and crook and hope to be back to normal tomorrow. […]
May 13 Biotech Update- As We Wait for ASCO
Another good start for the sector today and this is certainly feeling like a change in sentiment but we need to remain cautious. That being said, I would lean toward being a more aggressive buyer on pullbacks as we are finally starting to see some bids in the mid to small cap space. I have […]
May 8- The Biotech Draft
While there are some stock specific pieces of news, I want to do something a little different today in honor of the NFL draft. I am going to draft my top 10 stocks. This is assuming that I have no positions at all, so this is not what I would be buying now but if […]
March 25 Biotech Update- Would it Help to Cry Uncle?
Today certainly started as a better day in the sector but I would be careful of chasing this move. Ideally, we spend time building a base but a day or two of running is possible given the oversold conditions in the space. At this point I would lean towards the sector having put in a […]
March 24 Biotech Update- Being Kicked When You Are Down
Every sell off starts the bubble talk and the more severe the selling the more intense the bubble talk. What is interesting about this time is that the bubble talk has a broader audience as the sector seems to have been on more radars. As I have been saying for awhile, this sell off is […]
March 7 Biotech Update- Selling Feeding Selling
I am going to spend today talking about the sector in general and send this note out early in light of the significant sell off that started yesterday afternoon and continued this morning. While the bulk of the discussion seemed to center on GILD it should be noted that it was the sector that got […]
February 26 Biotech Update- Questions about Questions
The broader market and sector is more of the same so I will focus less on the macro simply because nothing has really changed. There are two stocks of interest this morning and both are fairly relevant, so I will get this note out sooner than usual and with less editing than usual (so it […]
February 11 Biotech Update- Some Positive Catalysts
It was a good day for the broader markets and a decent day for biotechs, although it seemed a little like a mixed bag with some stocks underperforming the rally. That being said simply following the broader market higher at this point is good for biotechs and likely means that this rally (relief or continuation) […]
